Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396))

the STAMPEDE investigators

doi:10.1016/j.annonc.2020.01.002

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396))

the STAMPEDE investigators

The Johnston Cancer Research Centre

Research output: Contribution to journal › Comment/debate › peer-review

5 Citations (Scopus)

118 Downloads (Pure)

Abstract

The authors regret that Fig.2F has been incorrectly titled. The correct title is “Failure-free survival high burden M1”.

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	31
Issue number	3
DOIs	https://doi.org/10.1016/j.annonc.2020.01.002
Publication status	Published - Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.annonc.2020.01.002

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE tria
© 2020 The Authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 129 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396))'. Together they form a unique fingerprint.

Cite this

@article{931c285de9474408bea748ec361b53b9,

title = "Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992{\textendash}2003) (5574397)(10.1093/annonc/mdz396))",

abstract = "The authors regret that Fig.2F has been incorrectly titled. The correct title is {\textquotedblleft}Failure-free survival high burden M1{\textquotedblright}.",

author = "Clarke, \{N. W.\} and A. Ali and Ingleby, \{F. C.\} and A. Hoyle and Amos, \{C. L.\} and G. Attard and Brawley, \{C. D.\} and J. Calvert and S. Chowdhury and A. Cook and W. Cross and Dearnaley, \{D. P.\} and H. Douis and D. Gilbert and S. Gillessen and Jones, \{R. J.\} and Langley, \{R. E.\} and A. MacNair and Z. Malik and Mason, \{M. D.\} and D. Matheson and R. Millman and Parker, \{C. C.\} and Ritchie, \{A. W.S.\} and H. Rush and Russell, \{J. M.\} and J. Brown and S. Beesley and A. Birtle and L. Capaldi and J. Gale and S. Gibbs and A. Lydon and A. Nikapota and A. Omlin and O'Sullivan, \{J. M.\} and O. Parikh and A. Protheroe and S. Rudman and Srihari, \{N. N.\} and M. Simms and Tanguay, \{J. S.\} and S. Tolan and J. Wagstaff and J. Wallace and J. Wylie and A. Zarkar and Sydes, \{M. R.\} and Parmar, \{M. K.B.\} and James, \{N. D.\} and \{the STAMPEDE investigators\}",

year = "2020",

month = mar,

doi = "10.1016/j.annonc.2020.01.002",

language = "English",

volume = "31",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "3",

}

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396)). / the STAMPEDE investigators.
In: Annals of Oncology, Vol. 31, No. 3, 03.2020.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396))

AU - Clarke, N. W.

AU - Ali, A.

AU - Ingleby, F. C.

AU - Hoyle, A.

AU - Amos, C. L.

AU - Attard, G.

AU - Brawley, C. D.

AU - Calvert, J.

AU - Chowdhury, S.

AU - Cook, A.

AU - Cross, W.

AU - Dearnaley, D. P.

AU - Douis, H.

AU - Gilbert, D.

AU - Gillessen, S.

AU - Jones, R. J.

AU - Langley, R. E.

AU - MacNair, A.

AU - Malik, Z.

AU - Mason, M. D.

AU - Matheson, D.

AU - Millman, R.

AU - Parker, C. C.

AU - Ritchie, A. W.S.

AU - Rush, H.

AU - Russell, J. M.

AU - Brown, J.

AU - Beesley, S.

AU - Birtle, A.

AU - Capaldi, L.

AU - Gale, J.

AU - Gibbs, S.

AU - Lydon, A.

AU - Nikapota, A.

AU - Omlin, A.

AU - O'Sullivan, J. M.

AU - Parikh, O.

AU - Protheroe, A.

AU - Rudman, S.

AU - Srihari, N. N.

AU - Simms, M.

AU - Tanguay, J. S.

AU - Tolan, S.

AU - Wagstaff, J.

AU - Wallace, J.

AU - Wylie, J.

AU - Zarkar, A.

AU - Sydes, M. R.

AU - Parmar, M. K.B.

AU - James, N. D.

AU - the STAMPEDE investigators

PY - 2020/3

Y1 - 2020/3

N2 - The authors regret that Fig.2F has been incorrectly titled. The correct title is “Failure-free survival high burden M1”.

AB - The authors regret that Fig.2F has been incorrectly titled. The correct title is “Failure-free survival high burden M1”.

UR - https://www.scopus.com/pages/publications/85079667705

U2 - 10.1016/j.annonc.2020.01.002

DO - 10.1016/j.annonc.2020.01.002

M3 - Comment/debate

C2 - 32067690

AN - SCOPUS:85079667705

SN - 0923-7534

VL - 31

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial (Ann Oncol (2019) 30 (1992–2003) (5574397)(10.1093/annonc/mdz396))

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this